Fennec Pharmaceuticals (FENC)

• Market cap: $303M
• 1 day: -2.93%
• 5 days: -1.49%
• 1 month: 11.67%
• 3 months: 9.13%
• 6 months: -0.81%
• Year to date: 12.11%
• 1 year: 27.56%
• 5 years: 17.62%
• 10 years: -28.25%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32